Scott Fidel
Stock Analyst at Stephens & Co.
(2.06)
# 2,225
Out of 4,827 analysts
183
Total ratings
50%
Success rate
7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health Partners | Reiterates: Overweight | $22 | $14.56 | +51.10% | 4 | Apr 1, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $110.70 | +28.27% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $28.17 | +34.90% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $95.20 | +6.09% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $183.77 | +21.35% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $15.42 | +10.25% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $62.42 | +16.95% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $385.55 | +75.07% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $10.60 | +192.45% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $333.11 | +23.08% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $136.28 | +22.54% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $25.48 | -17.58% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $253.35 | -1.32% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $412.38 | +49.13% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $115.91 | -9.41% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $325.86 | -1.80% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $149.06 | -18.15% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $24.22 | +279.85% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $353.92 | -20.89% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $1.35 | +6,937.04% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $5.50 | -72.73% | 3 | Nov 11, 2022 |
Ardent Health Partners
Apr 1, 2025
Reiterates: Overweight
Price Target: $22
Current: $14.56
Upside: +51.10%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $110.70
Upside: +28.27%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $28.17
Upside: +34.90%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $95.20
Upside: +6.09%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $183.77
Upside: +21.35%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $15.42
Upside: +10.25%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $62.42
Upside: +16.95%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $385.55
Upside: +75.07%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $10.60
Upside: +192.45%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $333.11
Upside: +23.08%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $136.28
Upside: +22.54%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $25.48
Upside: -17.58%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $253.35
Upside: -1.32%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $412.38
Upside: +49.13%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $115.91
Upside: -9.41%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $325.86
Upside: -1.80%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $149.06
Upside: -18.15%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $24.22
Upside: +279.85%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $353.92
Upside: -20.89%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $1.35
Upside: +6,937.04%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $5.50
Upside: -72.73%